Junior Medical Writer - Biostatistics & Clinical Evidence (German Native Speaker / Spain Remote) at IQVIA

Madrid, Community of Madrid, Spain

IQVIA Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalIndustries

Requirements

  • Advanced level of German language
  • Proficient in proofreading and editing in English language
  • Minimum of a Master's degree or educational equivalent in psychology, epidemiology, educational psychology, outcomes research, sociology, medicine, medical science or related field
  • Careful attention to detail and accuracy
  • Computer literate with knowledge of Microsoft Office applications
  • Ability to work in a fast-paced environment with demonstrated ability to effectively manage multiple tasks and projects

Responsibilities

  • Medical writing: describe indications, target patient populations and therapeutic needs as part of an HTA dossier
  • Calculation of annual therapy costs as part of an HTA (AMNOG) dossier
  • Understand clinical evidence on new compounds and assess study quality (using CONSORT) and bias potential as part of an HTA dossier
  • Interpret clinical study data from Clinical Study Reports

Skills

Medical Writing
HTA Dossier
AMNOG
CONSORT
Clinical Study Reports
Biostatistics
Statistical Methods
German Language
English Proofreading
Microsoft Office

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI